Chemotherapy-Induced Neuropathy Treatment in Murfreesboro, TN

Chemotherapy-Induced Neuropathy Treatment in Murfreesboro, TN — Advanced Non-Drug Nerve Care for Cancer Survivors

At Magnolia Medical Center, we provide specialized treatment for chemotherapy-induced peripheral neuropathy (CIPN) in Murfreesboro, TN, helping cancer survivors manage and recover from the lasting nerve damage that many chemotherapy agents cause. If you completed cancer treatment and are still dealing with neuropathy symptoms, our team offers a targeted, non-drug approach focused on nerve recovery and quality of life. Call (615) 953-9007 to schedule your evaluation.

Request an Appointment

What Is Chemotherapy-Induced Peripheral Neuropathy (CIPN)?

Chemotherapy-induced peripheral neuropathy is a common and often persistent side effect of certain cancer treatment drugs — including taxanes (paclitaxel, docetaxel), platinum-based agents (oxaliplatin, cisplatin), vinca alkaloids (vincristine), bortezomib, and thalidomide. These medications damage peripheral nerve fibers — particularly the sensory nerves — causing symptoms that may begin during treatment and persist or even worsen after treatment is completed.

CIPN symptoms include burning pain and numbness in the hands and feet, tingling and “pins and needles” sensations, extreme sensitivity to cold temperatures, muscle weakness, difficulty with fine motor tasks (buttoning, writing), and balance and coordination problems. For many cancer survivors, CIPN becomes a chronic condition that significantly impacts quality of life long after the cancer itself is in remission.

At Magnolia Medical Center in Murfreesboro, Tennessee, we have deep experience treating chemotherapy-induced neuropathy through our specialized neuropathy care program — providing compassionate, targeted care that helps cancer survivors reclaim their comfort and function.

Our Approach to Chemotherapy-Induced Neuropathy

Our CIPN treatment program at Magnolia Medical Center is designed to stimulate nerve repair, improve circulation to damaged nerve tissue, reduce pain signaling, and support the overall biological environment needed for nerve recovery. Treatment may include RST-Sanexas combined electrochemical therapy to deliver neuroregenerative electrical stimulation to damaged sensory nerve fibers. PEMF therapy to improve microvascular circulation and cellular energy in nerve tissue. Infrared and red light therapy to enhance mitochondrial function and blood flow in peripheral nerves. Vibration therapy to stimulate nerve endings and improve proprioception and balance. Nutrient injection therapy with B vitamins, alpha-lipoic acid, glutathione, and other neuroprotective nutrients. Oxygen therapy to improve tissue oxygenation in hypoxic nerve tissue. Shockwave therapy when musculoskeletal components contribute to symptom burden. Our compassionate team understands the complex health journey cancer survivors have experienced — and we approach CIPN care with respect for your full health picture and ongoing oncology relationships. Call (615) 953-9007 today.

Chemotherapy-Induced Neuropathy FAQs

Which chemotherapy drugs cause neuropathy?

Several classes of chemotherapy agents are associated with peripheral neuropathy. Platinum-based drugs (oxaliplatin, cisplatin, carboplatin), taxanes (paclitaxel, docetaxel), vinca alkaloids (vincristine), proteasome inhibitors (bortezomib), and immunomodulatory drugs (thalidomide, lenalidomide) are among the most common causes of CIPN. The likelihood and severity of neuropathy depends on the specific drug, cumulative dose, and individual patient factors. At Magnolia Medical Center in Murfreesboro, TN, we treat CIPN regardless of which agent caused it.

Does chemotherapy-induced neuropathy go away on its own?

For some patients, CIPN symptoms improve gradually over months after chemotherapy is completed. For many others, symptoms persist indefinitely or progress — particularly with platinum-based and taxane regimens. Without active treatment targeting nerve repair and circulation, improvement is often limited. Our specialized neuropathy care program at Magnolia Medical Center is designed to accelerate and maximize nerve recovery in patients who would otherwise experience chronic, persistent CIPN.

Is it safe to treat CIPN while still undergoing cancer treatment?

In most cases, our neuropathy therapies are safe and compatible with ongoing cancer treatment. However, we always coordinate with your oncology team before beginning treatment to ensure our care plan is appropriate for your current clinical situation. Your oncologist’s guidance is essential, and we work collaboratively with your full cancer care team. We focus on supporting your quality of life and nerve health throughout your recovery journey.

Can CIPN affect the hands as well as the feet?

Yes. Chemotherapy-induced neuropathy commonly affects both the feet and hands — producing the characteristic “stocking and glove” distribution seen in peripheral neuropathies. Hand symptoms include numbness, tingling, burning pain, cold sensitivity, and difficulty with fine motor tasks such as buttoning clothing, writing, or picking up small objects. At Magnolia Medical Center, we treat CIPN affecting both the upper and lower extremities through our comprehensive neuropathy care program.

What nutrients are helpful for chemotherapy-induced neuropathy?

Several nutrients have demonstrated benefit for CIPN, including B complex vitamins (B1, B6, B12) essential for nerve function and repair, alpha-lipoic acid (a powerful antioxidant that reduces neuropathic pain and supports nerve regeneration), glutathione (particularly relevant for platinum-based neuropathy as an antioxidant that protects nerve tissue), and acetyl-L-carnitine (supports mitochondrial function in nerve cells). At Magnolia Medical Center, we deliver these nutrients through targeted injection therapy for maximum bioavailability.

How soon after chemotherapy can I start neuropathy treatment?

Treatment can often begin as soon as your oncology team confirms it is safe — in many cases while you are still completing treatment, if symptoms are significantly affecting your quality of life. Early intervention gives damaged nerves the best opportunity for recovery. If you are a cancer survivor already past your treatment, it is never too late to pursue active neuropathy care. We encourage you to call (615) 953-9007 to schedule your evaluation at Magnolia Medical Center in Murfreesboro, TN.

How do I get started with chemotherapy-induced neuropathy treatment at Magnolia Medical Center?

Call (615) 953-9007 or request an appointment online to schedule your CIPN evaluation at Magnolia Medical Center in Murfreesboro, TN. We’ll conduct a thorough assessment of your neuropathy symptoms, treatment history, and current health status — in coordination with your oncology team — and design a personalized neuropathy care plan to support your nerve recovery and quality of life.

Call Us Appointments

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset